Revance Therapeutics (RVNC) Prices 5.88M Share Common Offering at $17/Sh
Tweet Send to a Friend
Revance Therapeutics, Inc. (NASDAQ: RVNC) today announced the pricing of an underwritten public offering of 5,882,353 shares of its common ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
